United States · FDA National Drug Code directory
Mirabegron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69238-2860_0bfa52f0-d4b2-4fb1-b3ee-da4cba2b18fd
- Product NDC
- 69238-2860
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Mirabegron
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260419
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRABEGRON — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2860-1) · 69238-2860-1
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2860-2) · 69238-2860-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →